3-OMe AG (Cap1) 100mM
3-OMe AG (Cap1) 100mM

CAS:2863631-10-9

  • 444
  • 445
100μL
HBP002808-1
1mL
HBP002808-2
10mL
HBP002808-3
100mL
HBP002808-4

Cat. No: HBP002808

Transportation and storage: Store at -20℃ or below, and shipped at ≤0℃.

Technical Support

Product Overview



GMP-grade Cap GAG (3'OMe) is a high-purity GMP-grade mRNA capping reagent manufactured in a GMP-compliant production environment with a completely animal origin-free process throughout the entire workflow. It is specifically designed for in vitro transcription (IVT), mRNA synthesis, and nucleic acid drug development applications, supporting the production of high-quality capped mRNA products.


With excellent purity, stringent quality control, and consistent batch performance, Cap GAG (3'OMe) meets the requirements of mRNA vaccine development, gene therapy research, and large-scale GMP mRNA manufacturing. It supports the complete mRNA development pipeline, from early-stage preclinical research and process development to commercial production.

CAS number 2863631-10-9
Molecular Weight 1159.69 (inner salt)
Molecular Formula C33H45N15O24P4(inner salt)
Purity >98%


Key Features


GMP-Grade Manufacturing


Cap GAG (3'OMe) is manufactured under a GMP-compliant production system with comprehensive quality control procedures to ensure high reliability, consistency, and suitability for mRNA drug manufacturing workflows.


High Purity and Excellent Quality Control


Produced with advanced purification processes to achieve purity greater than 98%, while minimizing impurities and ensuring stable performance in sensitive mRNA synthesis applications.


Ultra-Low Metal Residue


Strict control of metal impurities provides a cleaner reagent profile, supporting efficient enzymatic reactions and high-quality mRNA production.


Animal Origin-Free Process


The entire manufacturing workflow follows an animal origin-free process, meeting the quality and safety requirements of pharmaceutical and biotechnology applications.


High Batch-to-Batch Consistency


Controlled manufacturing processes and rigorous analytical testing ensure consistent product quality across multiple production batches.


Regulatory Support and Flexible Solutions


DMF filing support is available. A complete portfolio of mRNA capping reagents is provided, with customized specifications and packaging solutions available to meet different project requirements.



Applications


Cap GAG (3'OMe) is suitable for applications requiring high-quality mRNA capping reagents, including:

mRNA vaccine development and GMP manufacturing

Gene therapy drug research and development

In vitro transcription (IVT) mRNA synthesis

• Nucleic acid drug discovery and development

mRNA process development and optimization

• Preclinical research and GMP-scale production


It is designed to support the full lifecycle of mRNA therapeutics, from laboratory-scale research to commercial manufacturing.



FAQ


Q1: What is Cap GAG (3'OMe) used for?


Cap GAG (3'OMe) is an mRNA capping reagent used in in vitro transcription (IVT) and mRNA manufacturing processes. It is designed for applications including mRNA vaccines, gene therapy drugs, and nucleic acid therapeutics development.


Q2: Is Cap GAG (3'OMe) suitable for GMP-scale mRNA manufacturing?


Yes. Cap GAG (3'OMe) is produced in a GMP-compliant manufacturing environment with strict quality control standards and is suitable for applications ranging from preclinical research to commercial-scale mRNA production.


Q3: Is Cap GAG (3'OMe) manufactured using animal-derived materials?


No. The product is manufactured using a completely animal origin-free production process throughout the entire workflow.


Q4: What is the purity specification of Cap GAG (3'OMe)?


The purity of Cap GAG (3'OMe) is greater than 98%, ensuring reliable performance in mRNA synthesis and capping applications.


Q5: Does Cap GAG (3'OMe) support regulatory documentation?


Yes. DMF filing support is available to assist customers with pharmaceutical development and regulatory requirements.


Q6: How should Cap GAG (3'OMe) be stored and transported?


Cap GAG (3'OMe) should be transported under temperature-controlled conditions below 0°C and stored at -25°C to -15°C to maintain product stability.


Q7: Are customized product solutions available?


Yes. Customized requirements, including specifications and packaging options, can be supported according to customer research and manufacturing needs.



Related Products

Catalog No. Product Name Packing Specifications
HBP000330-1 T7 RNA Polymerase 50U/μL
HBP000330-2
HBP000330-3
HBP000330-4
HBP000340-1 T7 RNA Polymerase (low dsRNA) 50U/μL
HBP000340-2
HBP000340-3
HBP000340-4
HBP000350-1 T7 RNA Polymerase (thermostable) 50U/μL
HBP000350-2
HBP000350-3
HBP000350-4
HBP000401 RNase Inhibitor 40U/μL
HBP000402
HBP000406
HBP000403
HBP000404
HBP000405
HBP000501 Pyrophosphatase Inorganic (yeast) 0.1U/μL
HBP000502
HBP000505
HBP000503
HBP000504
HBP000606 Vaccinia Virus Capping Enzyme 10U/μL
HBP000607
HBP000611
HBP000608
HBP000609
HBP000610
HBP000701 mRNA Cap2'-O-Methyltransferase 50U/μL
HBP000702
HBP000706
HBP000703
HBP000910-1 DNase I 5U/μL
HBP000910-3
HBP000910-4
HBP000910-5
Message
Order Inquiry
Name *
Company *
Position *
Tel *
Mail *
Nation *

Do you have purchasing intention??

Requirement Description

Please contact on WhatsApp

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

  • iso_copy_copy
  • iso_copy
  • iso
  • iso_copy_copy
  • iso_copy
  • iso
Contact Us

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China.

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

Copyright © Hzymes Biotechnology Co., Ltd. All Rights Reserved Web design

Site Map | Legal Notice | Privacy Policy |

Contact Us